Keywords: interneuron, alter, obesity, drug, labeling, change, label

Interneuron To Alter Obesity Drug Labeling

Article | 09 September 1996

Interneuron will change the label on its Redux (dexfenfluramine) antiobesity drug to reflect a much greater risk of primary pulmonary ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in